Flow cytometry in oral cytology: Improved brush biopsy-based delineation of oral malignant and potentially malignant lesions
Journal of Clinical and Translational Research · 17.04.2026 · 12 (2) · 025180023
DOI: 10.36922/jctr025180023 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical and Translational Research, online erschienen am 17.04.2026. Verfasst von Pavithra Srinivasan und 22 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Brush biopsy is a minimally invasive method for early detection of oral squamous cell carcinoma (OSCC). Enhanced accuracy for clinical utility depends on analysis of the whole cell population and automated cohort classifications.
Aim
This study aims to delineate OSCC, high-grade dysplasia (HGD), and low-risk lesions (LRLs) by profiling single-cell level alterations using multiplexed flow cytometry.
Methods
Brush-biopsy samples were analyzed from patients with LRL, HGD, and OSCC. Flow cytometry analysis was standardized to ascertain cell distribution, heterogeneity, and epithelial cell content. Markers were used for epithelial cell (Pan-Cytokeratin [Pan-CK]/ propidium iodide [PI]) and atypical cell (Sambucus–Nigra–Agglutinin-1 [SNA-1]/ polyadenosine diphosphate-ribose polymerase inhibitor [PARPi-FL]) delineation. In addition, scatter properties and molecular-equivalence fluorescence (MEF) values of markers were analyzed for cohort classification.
Results
Brush-biopsy samples from OSCC/HGD patients showed heterogeneity in the percentage of Pan-CK+ve/PI+ve cells. Significant variation in MEF values of SNA-1/PARPi-FL/PI delineated the OSCC cohort (area under the curve > 0.85). Furthermore, the markers in combination with scatter properties delineated OSCC (multivariate logistic regression; sensitivity: 90%, specificity: 82%). The analysis of the forward-scatter height-to-area ratio delineated HGD from low-risk lesions by capturing the morphology-based cellular differences.
Conclusions
These results suggest that a flow cytometry-based analysis of brushbiopsy samples may serve as an adjunct tool for risk stratification of oral lesions. Relevance for patients: This study provides evidence towards the application of flow cytometry as an objective, quantitative adjunct to conventional cytology, and improves early detection and risk stratification of oral lesions using a minimally invasive sampling method, thereby supporting timely clinical decision-making and patient management.
Zitieren
APA
Srinivasan, P., Sunny, P. S. P., Vasudevan, V., Bonney, B., Hariharan, A., Mendonca, M., Mohan, U., Raghavan, S., Gurudath, S., Gurushanth, K., Hallikeri, A., Shetty, V., Bhushan, V., Dokhe, Y., Shivanand, N. B., Topajiche, S., Chandrashekhar, P., Pillai, V., Birur, P., …, & Kuriakose, M. A. (2026). Flow cytometry in oral cytology: Improved brush biopsy-based delineation of oral malignant and potentially malignant lesions. Journal of Clinical and Translational Research, 12(2), 025180023. https://doi.org/10.36922/jctr025180023
Vancouver
Srinivasan P, Sunny PSP, Vasudevan V, Bonney B, Hariharan A, Mendonca M, et al. Flow cytometry in oral cytology: Improved brush biopsy-based delineation of oral malignant and potentially malignant lesions. Journal of Clinical and Translational Research. 2026;12(2):025180023. doi:10.36922/jctr025180023
BibTeX
@article{Srinivasan2026,
author = {Srinivasan, Pavithra and Sunny, P. Sunny P. and Vasudevan, Vaishnav and Bonney, Bonney and Hariharan, Aditi and Mendonca, Mendonca and Mohan, Uma and Raghavan, Subhashini and Gurudath, Shubha and Gurushanth, Keerthi and Hallikeri, Ashwini and Shetty, Vivek and Bhushan, Vidya and Dokhe, Yogesh and Shivanand, Naveen B. and Topajiche, Satyajit and Chandrashekhar, Pavithra and Pillai, Vijay and Birur, Praveen and Brand, Christian and Reiner, Thomas and Suresh, Amritha and Kuriakose, Moni A.},
title = {Flow cytometry in oral cytology: Improved brush biopsy-based delineation of oral malignant and potentially malignant lesions},
journal = {Journal of Clinical and Translational Research},
year = {2026},
volume = {12},
number = {2},
pages = {025180023},
doi = {10.36922/jctr025180023}
}
EUVIMED